This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Current Status, Challenges, Issues
- Current Status:
- Trinity is 1/3 to ½ complete with implementation of Genesis
- Trinity has made limited progress with Genesis-enabled clinical transformation
- PGVA recommendations—focus on clinical process transformation to obtain value from Genesis
- Capturing and measuring value through improvement in clinical workflow
- Front-end customization to achieve adoption has led to proliferation of order sets that do not necessarily lead to better outcomes
- Missed expectations with some Cerner components
- Recognition of on-going software upgrade requirements
- Limited industry experience, high resource demand for "customizations", and personnel "burnout"
- Technical risk mitigation strategies
- Key Questions:
- How do we continue implementation while significantly ramping up clinical transformation?
- How do we increase value and reduce risk?
Great teams make real-time adjustments to the game plan to optimize outcomes
Op Revenue of Live Sites as % of TH Total = 35%
Op Expense of Lives Sites as % of TH Total = 35%
CMAED % of Live Sites as % of TH Total = 36%
FTE's % of Lives Sites as % of TH Total = 35.5%
Op Income of Live Sites as % of TH Total = 26%
Previous Slide Contents Next Slide